Skip to main content

ATXI

Avenue Therapeutics, Inc.

Company with tickers: ATXI

CIK
1644963
CUSIP
05360L403
Shares Outstanding
3,294,967
Investor Relations
https://avenuetx.com/investors/

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Repurchase History

Fiscal Year Ended Cash Spent
2023-12-31 $0
2022-12-31 $1,104,000